Nothing is ever as simple as it seems. With over 100,000 people on waiting lists at any given time for organ transplants in the United States alone, the possibility that organs will be able to be 3D printed seems heaven sent. We’ve seen the dramatic contributions 3D printing has made to other areas of medicine and to someone waiting for a life saving transplant procedure, the only question is simple and straightforward: ‘how quickly can we perfect this?’
Assuming that something as complex as printing human organs might actually be within the realm of possibilities, however, doesn’t mean that there aren’t external roadblocks. One of those comes in the form of patent laws. Yes, you read that right.
The key here is that the development of the processes and technology that will be required to execute such a complex task requires a great deal of capital investment. A lot of money needs to be poured into the research and there is no guarantee of success. This means that if Company X invests hundreds of millions of dollars in technology development, they will want to have exclusive rights to sell that technology, something that is guaranteed by a patent. Patents in the case of medicine are not new–pharmaceutical companies use them to protect their own research and development investments–instead it is the nature of the patent that is so unusual.
When printing human organs, however, you enter into a new and rarely before explored area of patent law will require a great deal of trial and error refinement. Current patent law states that “no patent may issue on a claim directed to or encompassing a human organism.” This language in the patent law was introduced in 2011 and so you might be tempted to think that it must be all cleared up and spelled out in great detail. Unfortunately that isn’t the case. In fact, there isn’t even any definition of what constitutes a ‘human organism’ something that could range from a single cell to any one of us.
Having such lack of precision in the statue will cause patent lawyers to have to tell their clients that they simply cannot determine whether or not the advances they make in the 3D printing of human organs will be something that they will be able to patent. The ambiguity in the code will require a number of decisions on the parts of the courts in order to clarify. That is a process that will take no small amount of time. Instead, it will undoubtedly slow down both the access to funding for this research, as investors face an even more uncertain future for returns, and the implementation of the technologies themselves as their status gets tied up in lengthy legal maneuvers.
Where there is a will, there is a way though and given unquenchable human curiosity and the ever larger number of minds that can come together and work on projects such as this, if it is possible to 3D print human organs, it will one day be done. As to whether or not the technology and procedures that make it a reality are something that can be patented, that’s something that the courts will have to decide. Given the commitment to open source design that is so heavily ingrained in 3D printing culture, combined with the nature of the Public Good to be done by providing increased access to life saving transplants, the more interesting question to ask may regard whether or not patents should be allowed to play any role at all.
In the meantime, consider signing up to be an organ donor, you don’t have to wait for patent law in order to be ready to be a hero.
What are your thoughts on the patenting of 3D printed human organs? Discuss in the 3D Printing Humans forum thread on 3DPB.com.
You May Also Like
Bioprinting with Frozen Cells: Multilayer Cryolithography for Better Cell Survival
UC Berkeley engineers may have finally found a realistic way to 3D print human organs. In their recently published paper, ‘A parallel multiple layer cryolithography device for the manufacture of...
Polish Company CD3D Opens Largest 3D Bioprinting Cluster in Europe
Centrum Druku 3D, or CD3D, is the largest online website devoted to 3D printing technology in Poland. Launched in 2013 with an online portal, the company’s operations are based on two...
A3DM Technologies and GPA Innova Advancing Post-Processing of Metal 3D Printed Parts with Unique Process
Vermont-based A3DM Technologies, which has long contributed to multiple commercial 3D printing production processes, and GPA Innova, founded in 2015 in Barcelona, recently entered into a collaborative research and development agreement...
SOLIDWORKSWORLD 2019: Global R&D Team Discusses New and Improved Features in SOLIDWORKS
Earlier this week, I arrived back home in chilly Ohio after spending a couple of days in Dallas, Texas. But I wasn’t just visiting the Lone Star State to enjoy...
View our broad assortment of in house and third party products.